Xeljanz Xr Adverse Event Report 2018

$19.99

This report includes data from the FDA’s Adverse Events Reports for 2018.  We removed reports where the subject of the report was taking only this drug. This report provides the following fields:

  • ID
  • Patient Summary
  • Patient Gender
  • Patient Age
  • Drug Products
  • Drug Reactions

Description

Xeljanz XR is used to treat moderate to severe rheumatoid arthritis or active psoriatic arthritis in adults who have tried methotrexate or other medications without successful treatment of symptoms. This medicine is sometimes given in combination with methotrexate or other arthritis medicines. Xeljanz XR is also used to treat adults with moderate to severe ulcerative colitis. Extended-release this medicine is not for use in treating ulcerative colitis. Xeljanz XR may also be used for purposes not listed in this medication guide.https://www.drugs.com/mtm/xeljanz-xr.html

Contact US

484-352-2642

What is an Adverse Event Report?

The FDA Adverse Event Reporting System (FAERS) is a database that contains adverse event reports, medication error reports and product quality complaints resulting in adverse events that were submitted to FDA.